Research News

- Read more about Triple-drug chemotherapy with topotecan helps preserve vision in retinoblastoma patients
St. Jude Children’s Research Hospital researchers report a topotecan-based chemotherapy regimen should be considered front-line therapy for patients with advanced bilateral retinoblastoma; an eye cancer in young children.
- Read more about Are natural alternatives to estrogen replacement therapy safe
Although individuals often consume natural products because of their potential health benefits, a new review indicates that it is not clear whether the benefits of plant-derived compounds that mimic estrogen outweigh the possible health risks. The findings are published in the British Journal of Pharmacology.
- Read more about Nivolumab reduces symptoms in relapsed metastatic head and neck cancer
Nivolumab maintains function and reduces symptoms in treatment of relapsed metastatic head and neck cancer, according to results from the CheckMate 141 trial presented at the ESMO 2016 Congress in Copenhagen1 and published in the New England Journal of Medicine.
- Read more about Janssen present New Phase 3 Data In Treatment of Moderate to Severe Plaque Psoriasis
Janssen Research & Development, LLC (Janssen) announced findings from the first of three pivotal Phase 3 studies evaluating guselkumab, a subcutaneously administered anti-interleukin (IL)-23 monoclonal antibody in late-stage development for the treatment of adults with moderate to severe plaque psoriasis.
- Read more about Sanofi Pasteur received approval for Dengvaxia® dengue vaccine
Sanofi Pasteur, the vaccines global business unit of Sanofi, announced Dengvaxia® dengue vaccine has now received its 11th marketing approval, four of which granted from Regulatory Authorities recognized by the World Health Organization (WHO). To date the vaccine is approved in Mexico, The Philippines, Brazil, El Salvador, Costa Rica, Paraguay, Guatemala, Peru, Indonesia, Thailand and Singapore.
- Read more about Life saving drug, D-Penicillamine is not availble in indian market
Life saving drug (D-Penicillamine) is not available across India. And CDSCO working faster on availability of drug in the market.
- Read more about Cancer Research UK, MSD and Verastem Collaborate to Trial New Combination of Immunotherapy Drugs
MSD, Verastem, Inc. and Cancer Research UK will trial a new combination of immunotherapy drugs in mesothelioma, non small cell lung and pancreatic cancers. The trial will run through the ECMC network at centres in Edinburgh-Dundee, Southampton, Glasgow, Leicester and Belfast.

[adsense:336x280:8701650588]
- Read more about Nanobiomed Inc® Discovered a New Nuclear Staining Molecule and Eco-Friendly Natural Source for Cancer Diagnostics: Prextrolin®
Nanobiomed Inc®., a nanomedicine and biotechnology company announced its leading-edge development of a new molecule for use in tissue and cancer diagnostics.
- Read more about Administering additional antibiotic prior to C-section reduces infection rates by 50%
“Infection during pregnancy and during the postpregnancy period is a major health problem for both mom and baby, and a common underlying cause of death,” said Alan T. N. Tita, M.D., Ph.D.; professor in the UAB Division of Maternal-Fetal Medicine and the Center for Women’s Reproductive Health, and principal investigator of the study. “Women who have a C-section are at significantly increased risk for infection compared to those who deliver vaginally. A major national goal is to reduce the risk of infection after surgery, and this finding is the culmination of investigative work over decades.”
- Read more about Omega-3 fatty acid called DHA, can stop a known trigger of lupus
A team of Michigan State University researchers has found that consuming an omega-3 fatty acid called DHA, or docosahexaenoic acid, can stop a known trigger of lupus and potentially other autoimmune disorders.